Biomaterials face challenges such as achieving biocompatibility and avoiding acute or chronic toxicity, genotoxicity, and immunotoxicity . Issues arise in protein adsorption on biomaterial surfaces, mechanical effects like wear, and biochemical interactions, including pH and fluid composition changes . These challenges affect the design and implementation of biomedical devices by necessitating rigorous testing and innovative solutions to minimize negative interactions and to ensure safety and efficacy . They must also maintain functionality and reliability while being physiologically acceptable .

Biomaterials have transitioned from inert substances primarily for prosthetics and structural support to active participants in biological processes like regeneration and therapy . This evolution impacts their development by requiring better biocompatibility, integration, and tailored degradation capabilities. The emphasis on active participation involves designing biomaterials that can support, stimulate, or integrate with biological tissues, facilitating healing and functional restoration . This shift has led to innovations in production techniques that prioritize the material's ability to communicate biologically with living tissues .

Biomaterials are classified based on their intended application: Class I includes permanent implants like hip replacements. Class II involves short-term implants to assist tissue repair. Class III covers invasive but removable devices like catheters. Class IV comprises external artificial organs such as dialysis units. Class V includes surgical accessories like wound dressings. Class VI involves drug and gene delivery systems. Class VII contains tissue engineering systems, while Class VIII covers in vivo diagnostic systems . Each class faces potential risks like toxicity, sensitization, and immunotoxicity .

Biomaterials are defined as materials of synthetic or natural origin intended for contact with tissue, blood, or body fluids to evaluate, treat, augment, or replace tissues, organs, or functions . Definitions have evolved from being materials chosen for inert contact with biological systems to those involved in regeneration and therapy . Over time, the focus shifted from simple replacement to functional integration and biocompatibility, reflecting advances in engineering and material sciences .

The introduction of silicone for breast implants in the 1960s reflected a shift in biomaterials toward aesthetic and reconstructive applications, emphasizing the need for materials that are not only functional but also socially and personally impactful . This change underscored challenges like ensuring long-term biocompatibility, addressing public health concerns, and regulatory scrutiny regarding potential adverse effects . It highlighted the crucial need for extended testing to ensure safety, durability, and patient satisfaction, shaping future development towards multifactorial considerations beyond immediate biomedical utility .

Osseointegration, discovered by Per-Ingvar Brånemark in 1952, dramatically impacted biomaterials by providing a foundational understanding of how living bone tissue can integrate with titanium surfaces . This discovery pioneered the development of highly effective dental and orthopedic implants, influencing materials science by prioritizing biocompatibility and tissue integration in design . It catalyzed numerous further innovations, including advancements in surface engineering to enhance integration and reduce rejection rates, ultimately enhancing patient outcomes and expanding the scope of implantable devices and techniques .

Intraocular lenses, developed by Harold Ridley after observing PMMA cockpit material injuries in pilots, marked a significant innovation in biomaterials by demonstrating safe and long-term integration into the eye . This development influenced the field by highlighting the importance of understanding material-tissue interactions and the potential for synthetic materials to function seamlessly within the body . Lessons from their development include the necessity of anticipating biological responses to foreign materials and the potential for cross-disciplinary applications of military-developed materials to medical technology .

The history of biomaterials began with prehistoric uses such as bone spearpoints lodged in skeletons. Ancient civilizations, like the Mayans, used nacre for dental implants, and ancient Egyptians employed sutures made from natural materials . The 19th century saw early attempts with artificial hearts and bone plates. Post-WWII advancements introduced materials like Teflon and titanium. Significant milestones include the development of intraocular lenses, osseointegration in titanium implants by Branemark in 1952, silicone for breast implants in the 1960s, and the first coronary artery stent in 1978 .

First generation biomaterials were ad hoc implants, chosen for their availability and often used by physicians for accidental successes, such as gold fillings and wooden teeth. Second generation biomaterials involved engineered implants developed collaboratively by physicians and engineers, often adapting materials from other industries, such as titanium alloy implants. Third generation biomaterials focus on bioengineering, using novel materials and regenerative strategies for integration and tissue regrowth, seen in artificial skin and cartilage cell therapy . These advances have contributed to more effective treatments, from simple mechanical support to facilitating biological interaction and regeneration .

The development of artificial organs like heart valves and vascular grafts in the mid-20th century introduced critical design considerations for biomaterials regarding biocompatibility and mechanical precision . These innovations highlighted the importance of selecting materials that can endure dynamic physiological conditions while interacting safely with body tissues . They significantly impacted patient outcomes, offering life-saving solutions and enhancing the quality of life for individuals with previously untreatable conditions, thus driving further research into safe, durable, and effective biomaterial applications .